Acepodia (6976:TT), a clinical-stage biotechnology company developing first-in-class cell therapies with its unique Antibody-Cell Conjugation (ACC) and allogeneic gamma delta 2 (γδ2) T cell platforms, ...

Nvidia (NVDA) invests in digital infrastructure solutions developer, Applied Digital (APLD), alongside other tech companies, ...

Aldeyra received an FDA CRL for reproxalap, necessitating an additional study for DED approval. Read why I continue to rate ...

In a report released today, Alicia Yap from Citi maintained a Buy rating on Baidu (BIDU – Research Report), with a price target of ...

Scholar Rock Holding ( (SRRK) ) has released its Q3 earnings. Here is a breakdown of the information Scholar Rock Holding presented to its ...

Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today reported financial results for the third ...

The repurchase was funded by Bankman-Fried's trading firm Alameda Research, but his second-in-command Caroline Ellison warned that “we don’t really have the money for this," according to a court ...

This paper introduces a novel approach to analyze the propagation mechanisms of stock market shocks within the S&P 500 Index, utilizing a Temporal Graph Convolutional Network ... Key findings from our ...

Clinical Cancer Research publishes articles that focus on innovative clinical and translational research bridging the laboratory and the clinic. Topics include targeted therapies; mechanisms of drug ...

Cancer Immunology Research publishes outstanding original articles reporting major advances in cancer immunology that span the discipline from basic investigations in host-tumor interactions to ...